■轻度创伤性脑损伤(mTBI)后的持续症状包括自主神经失调(AD)。复合自主神经症状评分,(COMPASS-31),用于量化去年AD症状的严重程度,这限制了临床应用。主要目的是确定与原始相比,上个月改良的COMPASS-31测量症状的有效性,其次,将原始版本和修改版本与神经行为症状量表(NSI)进行比较,并首先检测改良的COMPASS-31治疗后与NSI和头痛强度(HI)相比的变化。
■33名军事人员在mTBI后持续头痛。
■COMPASS-31的总分和域分数(原始与修改)基线时的NSI和HI。修改后的COMPASS-31的变化。NSI,和嗨。
■基线COMPASS-31版本具有可比性且高度相关(r=0.72,p<0.001),它们充其量与NSI适度相关(r<0.6),这可能表明测量指标的差异。改良COMPASS-31评分的平均变化(15.4/100,效应大小0.8)与HI评分的变化(r=0.39)轻度至中度相关,但不符合NSI(r=0.28)。
■修改后的COMPASS-31似乎有效,可以测量AD症状严重程度的变化,并建议作为结果度量。
UNASSIGNED: Persistent symptoms post-mild traumatic brain injury (mTBI) includes autonomic dysregulation (AD). The composite autonomic symptoms score, (COMPASS-31), was developed to quantify AD symptom severity in the last year, which limits clinical utility. The primary aim was to determine validity of a modified-COMPASS-31 measuring symptoms in the last month compared to the original, secondarily to compare both original and modified versions to the Neurobehavioral Symptom Inventory (NSI), and tertiarily to detect change post-treatment of the modified-COMPASS-31 compared to NSI and headache intensity (HI).
UNASSIGNED: Thirty-three military personnel with persistent headache post-mTBI.
UNASSIGNED: Total and domain scores for COMPASS-31 (original vs. modified) NSI and HI at baseline. Change in modified-COMPASS-31. NSI, and HI.
UNASSIGNED: Baseline COMPASS-31 versions were comparable and highly correlated (r = 0.72, p < 0.001), they were moderately correlated at best to the NSI (r < 0.6), which may suggest differences in measurement metrics. The mean change in modified-COMPASS-31 scores (15.4/100, effect size 0.8) was mild to moderately correlated to the change in HI (r = 0.39) score, but not to NSI (r = 0.28).
UNASSIGNED: The modified-COMPASS-31 appears to be valid, can measure change of AD symptom severity, and is recommended as an outcome measure.